Kalyan V Nadiminti

6PUBLICATIONS
40CO-AUTHORS
Gene and molecular therapyHaematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 17, 2026
Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.

|Aug 04, 2026
Boosting anti-leukemia cytotoxicity of CD4 and CD8 T cells through combined inhibition of MEK and HDAC.

|Nov 21, 2025
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

Andrew S Artz, Brent Logan, Wael Saber

|Sep 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study.

Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson

|Mar 24, 2023
Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.

Nicholas J Hess, David P Turicek, Jeremiah Riendeau

|Nov 21, 2021
A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.

Kalyan Nadiminti, Kimberly Langer, Ehsan Shabbir

Pageof 1

Frequent Collaborators

2 joint publications

Hassan B AlKhateeb

2 joint publications

William J Hogan

1 joint publications

Mrinal Patnaik

1 joint publications

Mithun Shah